| Tumors as organs: complex tissues that interface with the entire organism M Egeblad, ES Nakasone, Z Werb Developmental cell 18 (6), 884-901, 2010 | 1513 | 2010 |
| Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps J Park, RW Wysocki, Z Amoozgar, L Maiorino, MR Fein, J Jorns, AF Schott, ... Science translational medicine 8 (361), 361ra138-361ra138, 2016 | 847 | 2016 |
| Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance ES Nakasone, HA Askautrud, T Kees, JH Park, V Plaks, AJ Ewald, M Fein, ... Cancer cell 21 (4), 488-503, 2012 | 532 | 2012 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 306 | 2021 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 186 | 2021 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 50 | 2022 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 42 | 2021 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 34 | 2023 |
| Emergence of Raoultella ornithinolytica on O ‘ahu: a case of community-acquired R. ornithinolytica urinary tract infection ES Nakasone, R Kaneshiro, K Min, J Tokeshi Hawai'i Journal of Medicine & Public Health 74 (5), 174, 2015 | 32 | 2015 |
| Harnessing the immune system in the battle against breast cancer ES Nakasone, SA Hurvitz, KE McCann Drugs in context 7, 2018 | 29 | 2018 |
| A systematic framework to rapidly obtain data on patients with cancer and COVID-19: CCC19 governance, protocol, and quality assurance M Abidi, DM Aboulafia, MK Accordino, JD Acoba, MS Ahluwalia, ... Cancer cell 38 (6), 761-766, 2020 | 18 | 2020 |
| Live imaging of drug responses in the tumor microenvironment in mouse models of breast cancer ES Nakasone, HA Askautrud, M Egeblad JoVE (Journal of Visualized Experiments), e50088, 2013 | 18 | 2013 |
| Coinfections in patients with cancer and COVID-19: a COVID-19 and cancer consortium (CCC19) study G Satyanarayana, KT Enriquez, T Sun, EJ Klein, M Abidi, SM Advani, ... Open forum infectious diseases 9 (3), ofac037, 2022 | 13 | 2022 |
| Assessment of regional variability in COVID-19 outcomes among patients with cancer in the United States JE Hawley, T Sun, DD Chism, N Duma, JC Fu, NTN Gatson, S Mishra, ... JAMA network open 5 (1), e2142046-e2142046, 2022 | 9 | 2022 |
| A serendipitous find: a case of cholangiocarcinoma identified incidentally after acute liver injury due to cascara sagrada ingestion ES Nakasone, J Tokeshi Hawai'i Journal of Medicine & Public Health 74 (6), 200, 2015 | 6 | 2015 |
| Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study MJ Wagner, C Hennessy, A Beeghly, B French, DP Shah, S Croessmann, ... Cancers 14 (17), 4334, 2022 | 5 | 2022 |
| Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19 S Gulati, CY Hsu, S Shah, PK Shah, R Zon, S Alsamarai, J Awosika, ... JAMA oncology 9 (10), 1390-1400, 2023 | 4 | 2023 |
| Platelet and HIV Interactions and Their Contribution to Non-AIDS Comorbidities T Awamura, ES Nakasone, LM Gangcuangco, NT Subia, AJ Bali, ... Biomolecules 13 (11), 1608, 2023 | 3 | 2023 |
| Code status and outcomes in patients with cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) registry analysis. ET Loggers, EM Wulff-Burchfield, IM Subbiah, AR Khaki, P Egan, ... Journal of Clinical Oncology 39 (15_suppl), 12035-12035, 2021 | 2 | 2021 |
| Evaluating the utility of ZNF331 promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance) ES Nakasone, TJ Zemla, M Yu, SY Lin, FS Ou, K Carter, F Innocenti, ... Epigenetics 19 (1), 2349980, 2024 | 1 | 2024 |
